YD Bio Limited (YDESW)

Every figure this model derived for YDESW, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,440,019 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 6,007,615 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 9,670,190 AssetsCurrent 2025-12-31
current liabilities 1,643,578 LiabilitiesCurrent 2025-12-31
equity -2,855,663 StockholdersEquity 2025-12-31
interest expense 772 InterestExpenseNonoperating 2024-12-31
ocf -6,596,706 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 596,817 Revenues 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up YDESW on one particular measure came for.

RatioValue
cash operating margin-880.58
current ratio5.99
current ratio reported5.88
deferred revenue growth9.38
dilution pct3.07
fcf margin-1346.6
interest cover-6828.65
operating margin-883.31
owner earnings margin-1346.6
revenue growth16.94
revenue growth per share13.45
rule of 40-866.37
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about YDESW's figures. Written by the derivation as it ran, not added afterwards.